Paradigm Biopharmaceuticals (USA) Inc.

Musculoskeletal Pain in Knee Osteoarthritis

Paradigm Biopharmaceuticals (USA) Inc. focuses on clinical research in knee osteoarthritis pain, with attention to pain burden and functional limitation associated with degenerative joint disease.

  • Knee pain
  • Joint function
  • Osteoarthritis-related symptoms

The sponsor’s trial activity is centered on therapeutic evaluation in participants with symptomatic knee osteoarthritis.

Analgesic Therapy

Its research portfolio includes treatment-focused studies aimed at improving pain relief and daily mobility in people affected by chronic osteoarthritic pain.

  • Pain management
  • Mobility outcomes
  • Functional improvement

The therapeutic interest is directed toward interventions for persistent musculoskeletal discomfort and reduced physical performance.

Inflammatory Joint Disease

The sponsor’s clinical work also aligns with research into joint degeneration and the symptom profile of osteoarthritis, particularly where inflammation and structural wear contribute to pain.

  • Degenerative joint disease
  • Articular symptoms
  • Chronic joint discomfort

These studies reflect interest in therapies for the symptomatic management of lower-limb osteoarthritis.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on Pentosan Polysulfate Sodium for Knee Osteoarthritis Pain in Patients

    Not yet recruiting

    1 1 1
    Belgium
  • Study on the Effects of Pentosan Polysulfate Sodium for Knee Osteoarthritis Pain in Adults

    Not recruiting

    1 1 1
    Belgium Czechia Poland